Monthly
US$200
Billed every month
Febuxostat Tablets(非布司他片)
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 5 applicationsNo longer listed under review: 2 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders42View records ↓
Under-review filings14View records ↓
This year’s generic filers5View records ↓
NHSA approval numbers79View records ↓
API companies with A status34View records ↓
Chemical-drug catalogue
Loaded records: 42 holders; 3 in the quality-and-efficacy consistency-evaluation category, and 38 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 湖南千金湘江药业股份有限公司 | 湖南千金湘江药业股份有限公司 | 国药准字H20264760 | 2026/06/10 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南千金湘江药业股份有限公司 | 湖南千金湘江药业股份有限公司 | 国药准字H20264761 | 2026/06/10 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 多多药业有限公司 | 多多药业有限公司 | 国药准字H20264193 | 2026/04/29 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 多多药业有限公司 | 多多药业有限公司 | 国药准字H20264192 | 2026/04/29 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 四川新斯顿制药股份有限公司 | 四川新斯顿制药股份有限公司 | 国药准字H20263475 | 2026/02/25 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 温岭市创新生物医药科技股份有限公司 | 浙江赛默制药有限公司 | 国药准字H20263336 | 2026/02/02 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 温岭市创新生物医药科技股份有限公司 | 浙江赛默制药有限公司 | 国药准字H20263337 | 2026/02/02 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河北万岁药业有限公司 | 河北万岁药业有限公司 | 国药准字H20256399 | 2025/12/22 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河北万岁药业有限公司 | 河北万岁药业有限公司 | 国药准字H20256400 | 2025/12/22 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 陕西西岳制药有限公司 | 陕西西岳制药有限公司 | 国药准字H20256296 | 2025/12/16 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 陕西西岳制药有限公司 | 陕西西岳制药有限公司 | 国药准字H20256297 | 2025/12/16 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 宁波美诺华天康药业有限公司 | 宁波美诺华天康药业有限公司 | 国药准字H20256168 | 2025/12/03 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 宁波美诺华天康药业有限公司 | 宁波美诺华天康药业有限公司 | 国药准字H20256169 | 2025/12/03 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖北亨迪药业股份有限公司 | 湖北亨迪药业股份有限公司 | 国药准字H20255686 | 2025/10/14 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖北亨迪药业股份有限公司 | 湖北亨迪药业股份有限公司 | 国药准字H20255685 | 2025/10/14 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 四川依科制药有限公司 | 四川依科制药有限公司 | 国药准字H20255108 | 2025/08/19 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 四川依科制药有限公司 | 四川依科制药有限公司 | 国药准字H20255107 | 2025/08/19 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 吉林省辉南长龙生化药业股份有限公司 | 吉林省辉南长龙生化药业股份有限公司 | 国药准字H20258145 | 2025/07/28 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广州汇元医药科技有限公司 | 中山可可康制药有限公司 | 国药准字H20253470 | 2025/02/25 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖北广济药业股份有限公司 | 湖北广济药业股份有限公司 | 国药准字H20249847 | 2024/12/25 | 40mg | Not stated by source | CDE |
| 湖北广济药业股份有限公司 | 湖北广济药业股份有限公司 | 国药准字H20249848 | 2024/12/25 | 20mg | Not stated by source | CDE |
| 宜昌人福药业有限责任公司 | 宜昌人福药业有限责任公司 | 国药准字H20247281 | 2024/11/07 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东淄博新达制药有限公司 | 山东淄博新达制药有限公司 | 国药准字H20249271 | 2024/11/05 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河北爱普制药有限公司 | 河北爱普制药有限公司 | 国药准字H20249298 | 2024/11/05 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 华润双鹤药业股份有限公司 | 华润双鹤药业股份有限公司 | 国药准字H20247261 | 2024/10/29 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东鲁抗医药股份有限公司 | 山东鲁抗医药股份有限公司 | 国药准字H20249008 | 2024/09/26 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东鲁抗医药股份有限公司 | 山东鲁抗医药股份有限公司 | 国药准字H20249007 | 2024/09/26 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 涿州东乐制药有限公司 | 涿州东乐制药有限公司 | 国药准字H20243755 | 2024/05/21 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏德源药业股份有限公司 | 江苏德源药业股份有限公司 | 国药准字H20243126 | 2024/01/30 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江华海药业股份有限公司 | 浙江华海药业股份有限公司 | 国药准字H20243042 | 2024/01/09 | 80mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 南京海辰药业股份有限公司 | 南京海辰药业股份有限公司 | 国药准字H20243014 | 2024/01/09 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 南京海辰药业股份有限公司 | 南京海辰药业股份有限公司 | 国药准字H20243013 | 2024/01/09 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江华海药业股份有限公司 | 浙江华海药业股份有限公司 | 国药准字H20243041 | 2024/01/09 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 吉林省辉南长龙生化药业股份有限公司 | 吉林省辉南长龙生化药业股份有限公司 | 国药准字H20234672 | 2023/12/19 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 芜湖杨燕制药有限公司 | 华益药业科技（安徽）有限公司 | 国药准字H20233931 | 2023/07/25 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 芜湖杨燕制药有限公司 | 华益药业科技（安徽）有限公司 | 国药准字H20233932 | 2023/07/25 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江诺得药业有限公司 | 浙江诺得药业有限公司 | 国药准字H20233825 | 2023/06/30 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 华润双鹤药业股份有限公司 | 华润双鹤药业股份有限公司 | 国药准字H20233734 | 2023/06/14 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江亚太药业股份有限公司 | 浙江亚太药业股份有限公司 | 国药准字H20233473 | 2023/04/17 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 青岛百洋制药有限公司 | 青岛百洋制药有限公司 | 国药准字H20233438 | 2023/04/11 | 80mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 青岛百洋制药有限公司 | 青岛百洋制药有限公司 | 国药准字H20233437 | 2023/04/11 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 青岛黄海制药有限责任公司 | 青岛黄海制药有限责任公司 | 国药准字H20233302 | 2023/03/21 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 青岛黄海制药有限责任公司 | 青岛黄海制药有限责任公司 | 国药准字H20233303 | 2023/03/21 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 西洲医药科技（浙江）有限公司 | 浙江北生药业汉生制药有限公司 | 国药准字H20233318 | 2023/03/21 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 西洲医药科技（浙江）有限公司 | 浙江北生药业汉生制药有限公司 | 国药准字H20233319 | 2023/03/21 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 福安药业集团烟台只楚药业有限公司 | 福安药业集团烟台只楚药业有限公司 | 国药准字H20233188 | 2023/02/14 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 福安药业集团烟台只楚药业有限公司 | 福安药业集团烟台只楚药业有限公司 | 国药准字H20233189 | 2023/02/14 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江西施美药业股份有限公司 | 江西施美药业股份有限公司 | 国药准字H20233130 | 2023/02/07 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江西施美药业股份有限公司 | 江西施美药业股份有限公司 | 国药准字H20233131 | 2023/02/07 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 杭州华东医药集团浙江华义制药有限公司 | 杭州华东医药集团浙江华义制药有限公司 | 国药准字H20223767 | 2022/10/25 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 杭州华东医药集团浙江华义制药有限公司 | 杭州华东医药集团浙江华义制药有限公司 | 国药准字H20223766 | 2022/10/25 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都倍特药业股份有限公司 | 成都倍特药业股份有限公司 | 国药准字H20213927 | 2021/12/08 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都倍特药业股份有限公司 | 成都倍特药业股份有限公司 | 国药准字H20213926 | 2021/12/08 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 重庆圣华曦药业股份有限公司 | 重庆圣华曦药业股份有限公司 | 国药准字H20213859 | 2021/11/17 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东朗诺制药有限公司 | 山东朗诺制药有限公司 | 国药准字H20213864 | 2021/11/17 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 重庆圣华曦药业股份有限公司 | 重庆圣华曦药业股份有限公司 | 国药准字H20213860 | 2021/11/17 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 南京海纳制药有限公司 | 南京海纳制药有限公司 | 国药准字H20213720 | 2021/09/13 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 南京海纳制药有限公司 | 南京海纳制药有限公司 | 国药准字H20213719 | 2021/09/13 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏恒瑞医药股份有限公司 | 江苏恒瑞医药股份有限公司 | 国药准字H20213689 | 2021/09/01 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 东莞市阳之康医药有限责任公司 | 广东东阳光药业有限公司 | 国药准字H20213325 | 2021/04/30 | 80mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 东莞市阳之康医药有限责任公司 | 广东东阳光药业有限公司 | 国药准字H20213324 | 2021/04/30 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏华世通生物医药科技有限公司 | 江苏中天药业有限公司 | 国药准字H20213171 | 2021/03/09 | 20mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏华世通生物医药科技有限公司 | 江苏中天药业有限公司 | 国药准字H20213172 | 2021/03/09 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 南京海纳医药科技股份有限公司 | 南京海纳制药有限公司 | 国药准字H20213092 | 2021/02/02 | 80mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 南京海纳医药科技股份有限公司 | 南京海纳制药有限公司 | 国药准字H20213091 | 2021/02/02 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 杭州朱养心药业有限公司 | 杭州朱养心药业有限公司 | 国药准字H20205030 | 2020/09/08 | 20mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 杭州朱养心药业有限公司 | 国药准字H20130009 | 2020/07/16 | 40mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 江苏恒瑞医药股份有限公司 | 国药准字H20130081 | 2020/04/21 | 40mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 江苏万邦生化医药集团有限责任公司 | 国药准字H20130059 | 2020/04/07 | 80mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 江苏万邦生化医药集团有限责任公司 | 国药准字H20130058 | 2020/04/07 | 40mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| TEIJIN PHARMA LIMITED | TEIJIN PHARMA LIMITED IWAKUNI PHARMACEUTICAL FACTORY | H20180050;H20181258 | 2018/09/04 | 40mg | Imported originator drug (进口原研药品) | CDE |
| TEIJIN PHARMA LIMITED | TEIJIN PHARMA LIMITED IWAKUNI PHARMACEUTICAL FACTORY | H20180051;H20181257 | 2018/09/04 | 20mg | Imported originator drug (进口原研药品) | CDE |
| 海南林恒制药股份有限公司 | 海南林恒制药股份有限公司 | 国药准字H20243520 | 2024/04/17 | 40mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 79 distinct approval numbers and 45 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 一力制药(罗定)有限公司 | 国药准字H20223640 | 40mg | Category B (乙) | XM04AAF670A001010100311 | NHSA |
| 广东恒健制药有限公司 | 国药准字H20254761 | 20mg | Category B (乙) | XM04AAF670A001010100443 | NHSA |
| TEIJIN PHARMA LIMITED | 国药准字HJ20180051 | 20mg | Category B (乙) | XM04AAF670A001010101076 | NHSA |
| 江苏恒瑞医药股份有限公司 | 国药准字H20130081 | 40mg | Category B (乙) | XM04AAF670A001010101445 | NHSA |
| 南京海辰药业股份有限公司 | 国药准字H20243014 | 20mg | Category B (乙) | XM04AAF670A001010101563 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20130058 | 40mg | Category B (乙) | XM04AAF670A001010101729 | NHSA |
| 湖北广济药业股份有限公司 | 国药准字H20249847 | 40mg | Category B (乙) | XM04AAF670A001010101803 | NHSA |
| 宜昌人福药业有限责任公司 | 国药准字H20233871 | 40mg | Category B (乙) | XM04AAF670A001010102000 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20213927 | 20mg | Category B (乙) | XM04AAF670A001010102013 | NHSA |
| 四川依科制药有限公司 | 国药准字H20255108 | 40mg | Category B (乙) | XM04AAF670A001010102251 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20263475 | 40mg | Category B (乙) | XM04AAF670A001010102273 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256296 | 40mg | Category B (乙) | XM04AAF670A001010102439 | NHSA |
| 河北万岁药业有限公司 | 国药准字H20256399 | 40mg | Category B (乙) | XM04AAF670A001010102667 | NHSA |
| 河北爱普制药有限公司 | 国药准字H20249298 | 40mg | Category B (乙) | XM04AAF670A001010102756 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20243755 | 40mg | Category B (乙) | XM04AAF670A001010102833 | NHSA |
| 吉林省辉南长龙生化药业股份有限公司 | 国药准字H20234672 | 40mg | Category B (乙) | XM04AAF670A001010103421 | NHSA |
| 山东力诺制药有限公司 | 国药准字H20233437 | 40mg | Category B (乙) | XM04AAF670A001010104023 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20233303 | 40mg | Category B (乙) | XM04AAF670A001010104043 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233188 | 40mg | Category B (乙) | XM04AAF670A001010104251 | NHSA |
| 杭州朱养心药业有限公司 | 国药准字H20130009 | 40mg | Category B (乙) | XM04AAF670A001010104522 | NHSA |
| 宁波美诺华天康药业有限公司 | 国药准字H20256168 | 40mg | Category B (乙) | XM04AAF670A001010104565 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20243041 | 40mg | Category B (乙) | XM04AAF670A001010104647 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20223767 | 20mg | Category B (乙) | XM04AAF670A001010104650 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20233472 | 40mg | Category B (乙) | XM04AAF670A001010104744 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20264761 | 40mg | Category B (乙) | XM04AAF670A001010104960 | NHSA |
| 山西兰花药业股份有限公司 | 国药准字H20233130 | 40mg | Category B (乙) | XM04AAF670A001010105356 | NHSA |
| 海南林恒制药股份有限公司 | 国药准字H20243520 | 40mg | Category B (乙) | XM04AAF670A001010105792 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20243126 | 40mg | Category B (乙) | XM04AAF670A001010106632 | NHSA |
| 宜昌东阳光长江药业股份有限公司 | 国药准字H20213324 | 40mg | Category B (乙) | XM04AAF670A001010106988 | NHSA |
| 重庆圣华曦药业股份有限公司 | 国药准字H20213859 | 20mg | Category B (乙) | XM04AAF670A001010109568 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20213864 | 40mg | Category B (乙) | XM04AAF670A001010110323 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20213091 | 40mg | Category B (乙) | XM04AAF670A001010180537 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213171 | 20mg | Category B (乙) | XM04AAF670A001010181457 | NHSA |
| 华润双鹤药业股份有限公司 | 国药准字H20233734 | 40mg | Category B (乙) | XM04AAF670A001010181661 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20249007 | 20mg | Category B (乙) | XM04AAF670A001010183198 | NHSA |
| 山东淄博新达制药有限公司 | 国药准字H20249271 | 20mg | Category B (乙) | XM04AAF670A001010183219 | NHSA |
| 湖北亨迪药业股份有限公司 | 国药准字H20255685 | 40mg | Category B (乙) | XM04AAF670A001010183405 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001010183521 | NHSA |
| 广州汇元医药科技有限公司 | 国药准字H20253470 | 40mg | Category B (乙) | XM04AAF670A001010183670 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20233318 | 20mg | Category B (乙) | XM04AAF670A001010184209 | NHSA |
| 浙江赛默制药有限公司 | 国药准字H20263336 | 40mg | Category B (乙) | XM04AAF670A001010184214 | NHSA |
| 昆明龙津药业股份有限公司 | 国药准字H20233931 | 20mg | Category B (乙) | XM04AAF670A001010184519 | NHSA |
| 湖南状元制药有限公司 | 国药准字H20264929 | 80mg | Category B (乙) | XM04AAF670A001010184775 | NHSA |
| 一力制药(罗定)有限公司 | 国药准字H20223640 | 40mg | Category B (乙) | XM04AAF670A001010200311 | NHSA |
| 江苏恒瑞医药股份有限公司 | 国药准字H20130081 | 40mg | Category B (乙) | XM04AAF670A001010201445 | NHSA |
| 南京海辰药业股份有限公司 | 国药准字H20243014 | 20mg | Category B (乙) | XM04AAF670A001010201563 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20130058 | 40mg | Category B (乙) | XM04AAF670A001010201729 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20213927 | 20mg | Category B (乙) | XM04AAF670A001010202013 | NHSA |
| 四川依科制药有限公司 | 国药准字H20255108 | 40mg | Category B (乙) | XM04AAF670A001010202251 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20263475 | 40mg | Category B (乙) | XM04AAF670A001010202273 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256296 | 40mg | Category B (乙) | XM04AAF670A001010202439 | NHSA |
| 河北万岁药业有限公司 | 国药准字H20256399 | 40mg | Category B (乙) | XM04AAF670A001010202667 | NHSA |
| 河北爱普制药有限公司 | 国药准字H20249298 | 40mg | Category B (乙) | XM04AAF670A001010202756 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20243755 | 40mg | Category B (乙) | XM04AAF670A001010202833 | NHSA |
| 吉林省辉南长龙生化药业股份有限公司 | 国药准字H20234672 | 40mg | Category B (乙) | XM04AAF670A001010203421 | NHSA |
| 山东力诺制药有限公司 | 国药准字H20233437 | 40mg | Category B (乙) | XM04AAF670A001010204023 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20233303 | 40mg | Category B (乙) | XM04AAF670A001010204043 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233188 | 40mg | Category B (乙) | XM04AAF670A001010204251 | NHSA |
| 杭州朱养心药业有限公司 | 国药准字H20130009 | 40mg | Category B (乙) | XM04AAF670A001010204522 | NHSA |
| 宁波美诺华天康药业有限公司 | 国药准字H20256168 | 40mg | Category B (乙) | XM04AAF670A001010204565 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20243041 | 40mg | Category B (乙) | XM04AAF670A001010204647 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20223767 | 20mg | Category B (乙) | XM04AAF670A001010204650 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20233472 | 40mg | Category B (乙) | XM04AAF670A001010204744 | NHSA |
| 山西兰花药业股份有限公司 | 国药准字H20233130 | 40mg | Category B (乙) | XM04AAF670A001010205356 | NHSA |
| 海南林恒制药股份有限公司 | 国药准字H20243520 | 40mg | Category B (乙) | XM04AAF670A001010205792 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20243126 | 40mg | Category B (乙) | XM04AAF670A001010206632 | NHSA |
| 宜昌东阳光长江药业股份有限公司 | 国药准字H20213324 | 40mg | Category B (乙) | XM04AAF670A001010206988 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20213864 | 40mg | Category B (乙) | XM04AAF670A001010210323 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20213091 | 40mg | Category B (乙) | XM04AAF670A001010280537 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213171 | 20mg | Category B (乙) | XM04AAF670A001010281457 | NHSA |
| 华润双鹤药业股份有限公司 | 国药准字H20233734 | 40mg | Category B (乙) | XM04AAF670A001010281661 | NHSA |
| 山东淄博新达制药有限公司 | 国药准字H20249271 | 20mg | Category B (乙) | XM04AAF670A001010283219 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001010283521 | NHSA |
| 广州汇元医药科技有限公司 | 国药准字H20253470 | 40mg | Category B (乙) | XM04AAF670A001010283670 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20233318 | 20mg | Category B (乙) | XM04AAF670A001010284209 | NHSA |
| 浙江赛默制药有限公司 | 国药准字H20263336 | 40mg | Category B (乙) | XM04AAF670A001010284214 | NHSA |
| 昆明龙津药业股份有限公司 | 国药准字H20233931 | 20mg | Category B (乙) | XM04AAF670A001010284519 | NHSA |
| 一力制药(罗定)有限公司 | 国药准字H20223640 | 40mg | Category B (乙) | XM04AAF670A001010300311 | NHSA |
| 南京海辰药业股份有限公司 | 国药准字H20243014 | 20mg | Category B (乙) | XM04AAF670A001010301563 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20130058 | 40mg | Category B (乙) | XM04AAF670A001010301729 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20213927 | 20mg | Category B (乙) | XM04AAF670A001010302013 | NHSA |
| 四川依科制药有限公司 | 国药准字H20255108 | 40mg | Category B (乙) | XM04AAF670A001010302251 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20263475 | 40mg | Category B (乙) | XM04AAF670A001010302273 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256296 | 40mg | Category B (乙) | XM04AAF670A001010302439 | NHSA |
| 河北万岁药业有限公司 | 国药准字H20256399 | 40mg | Category B (乙) | XM04AAF670A001010302667 | NHSA |
| 河北爱普制药有限公司 | 国药准字H20249298 | 40mg | Category B (乙) | XM04AAF670A001010302756 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20243755 | 40mg | Category B (乙) | XM04AAF670A001010302833 | NHSA |
| 吉林省辉南长龙生化药业股份有限公司 | 国药准字H20234672 | 40mg | Category B (乙) | XM04AAF670A001010303421 | NHSA |
| 山东力诺制药有限公司 | 国药准字H20233437 | 40mg | Category B (乙) | XM04AAF670A001010304023 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20233303 | 40mg | Category B (乙) | XM04AAF670A001010304043 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233188 | 40mg | Category B (乙) | XM04AAF670A001010304251 | NHSA |
| 杭州朱养心药业有限公司 | 国药准字H20130009 | 40mg | Category B (乙) | XM04AAF670A001010304522 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20243041 | 40mg | Category B (乙) | XM04AAF670A001010304647 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20223767 | 20mg | Category B (乙) | XM04AAF670A001010304650 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20233472 | 40mg | Category B (乙) | XM04AAF670A001010304744 | NHSA |
| 海南林恒制药股份有限公司 | 国药准字H20243520 | 40mg | Category B (乙) | XM04AAF670A001010305792 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20243126 | 40mg | Category B (乙) | XM04AAF670A001010306632 | NHSA |
| 宜昌东阳光长江药业股份有限公司 | 国药准字H20213324 | 40mg | Category B (乙) | XM04AAF670A001010306988 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20213864 | 40mg | Category B (乙) | XM04AAF670A001010310323 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20213091 | 40mg | Category B (乙) | XM04AAF670A001010380537 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213171 | 20mg | Category B (乙) | XM04AAF670A001010381457 | NHSA |
| 华润双鹤药业股份有限公司 | 国药准字H20233734 | 40mg | Category B (乙) | XM04AAF670A001010381661 | NHSA |
| 山东淄博新达制药有限公司 | 国药准字H20249271 | 20mg | Category B (乙) | XM04AAF670A001010383219 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001010383521 | NHSA |
| 广州汇元医药科技有限公司 | 国药准字H20253470 | 40mg | Category B (乙) | XM04AAF670A001010383670 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20233318 | 20mg | Category B (乙) | XM04AAF670A001010384209 | NHSA |
| 一力制药(罗定)有限公司 | 国药准字H20223640 | 40mg | Category B (乙) | XM04AAF670A001010400311 | NHSA |
| 南京海辰药业股份有限公司 | 国药准字H20243014 | 20mg | Category B (乙) | XM04AAF670A001010401563 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20130058 | 40mg | Category B (乙) | XM04AAF670A001010401729 | NHSA |
| 四川依科制药有限公司 | 国药准字H20255108 | 40mg | Category B (乙) | XM04AAF670A001010402251 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20263475 | 40mg | Category B (乙) | XM04AAF670A001010402273 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256296 | 40mg | Category B (乙) | XM04AAF670A001010402439 | NHSA |
| 河北爱普制药有限公司 | 国药准字H20249298 | 40mg | Category B (乙) | XM04AAF670A001010402756 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20243755 | 40mg | Category B (乙) | XM04AAF670A001010402833 | NHSA |
| 吉林省辉南长龙生化药业股份有限公司 | 国药准字H20234672 | 40mg | Category B (乙) | XM04AAF670A001010403421 | NHSA |
| 山东力诺制药有限公司 | 国药准字H20233437 | 40mg | Category B (乙) | XM04AAF670A001010404023 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20233303 | 40mg | Category B (乙) | XM04AAF670A001010404043 | NHSA |
| 杭州朱养心药业有限公司 | 国药准字H20130009 | 40mg | Category B (乙) | XM04AAF670A001010404522 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20233472 | 40mg | Category B (乙) | XM04AAF670A001010404744 | NHSA |
| 海南林恒制药股份有限公司 | 国药准字H20243520 | 40mg | Category B (乙) | XM04AAF670A001010405792 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20243126 | 40mg | Category B (乙) | XM04AAF670A001010406632 | NHSA |
| 宜昌东阳光长江药业股份有限公司 | 国药准字H20213324 | 40mg | Category B (乙) | XM04AAF670A001010406988 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20213864 | 40mg | Category B (乙) | XM04AAF670A001010410323 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20213091 | 40mg | Category B (乙) | XM04AAF670A001010480537 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213171 | 20mg | Category B (乙) | XM04AAF670A001010481457 | NHSA |
| 山东淄博新达制药有限公司 | 国药准字H20249271 | 20mg | Category B (乙) | XM04AAF670A001010483219 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001010483521 | NHSA |
| 广州汇元医药科技有限公司 | 国药准字H20253470 | 40mg | Category B (乙) | XM04AAF670A001010483670 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20233318 | 20mg | Category B (乙) | XM04AAF670A001010484209 | NHSA |
| 一力制药(罗定)有限公司 | 国药准字H20223640 | 40mg | Category B (乙) | XM04AAF670A001010500311 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20130058 | 40mg | Category B (乙) | XM04AAF670A001010501729 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20263475 | 40mg | Category B (乙) | XM04AAF670A001010502273 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256296 | 40mg | Category B (乙) | XM04AAF670A001010502439 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20243755 | 40mg | Category B (乙) | XM04AAF670A001010502833 | NHSA |
| 吉林省辉南长龙生化药业股份有限公司 | 国药准字H20234672 | 40mg | Category B (乙) | XM04AAF670A001010503421 | NHSA |
| 山东力诺制药有限公司 | 国药准字H20233437 | 40mg | Category B (乙) | XM04AAF670A001010504023 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20233303 | 40mg | Category B (乙) | XM04AAF670A001010504043 | NHSA |
| 杭州朱养心药业有限公司 | 国药准字H20130009 | 40mg | Category B (乙) | XM04AAF670A001010504522 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20233472 | 40mg | Category B (乙) | XM04AAF670A001010504744 | NHSA |
| 海南林恒制药股份有限公司 | 国药准字H20243520 | 40mg | Category B (乙) | XM04AAF670A001010505792 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20243126 | 40mg | Category B (乙) | XM04AAF670A001010506632 | NHSA |
| 宜昌东阳光长江药业股份有限公司 | 国药准字H20213324 | 40mg | Category B (乙) | XM04AAF670A001010506988 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20213864 | 40mg | Category B (乙) | XM04AAF670A001010510323 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20213091 | 40mg | Category B (乙) | XM04AAF670A001010580537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001010583521 | NHSA |
| 广州汇元医药科技有限公司 | 国药准字H20253470 | 40mg | Category B (乙) | XM04AAF670A001010583670 | NHSA |
| 一力制药(罗定)有限公司 | 国药准字H20223640 | 40mg | Category B (乙) | XM04AAF670A001010600311 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20130058 | 40mg | Category B (乙) | XM04AAF670A001010601729 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20263475 | 40mg | Category B (乙) | XM04AAF670A001010602273 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256296 | 40mg | Category B (乙) | XM04AAF670A001010602439 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20243755 | 40mg | Category B (乙) | XM04AAF670A001010602833 | NHSA |
| 山东力诺制药有限公司 | 国药准字H20233437 | 40mg | Category B (乙) | XM04AAF670A001010604023 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20233303 | 40mg | Category B (乙) | XM04AAF670A001010604043 | NHSA |
| 杭州朱养心药业有限公司 | 国药准字H20130009 | 40mg | Category B (乙) | XM04AAF670A001010604522 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20233472 | 40mg | Category B (乙) | XM04AAF670A001010604744 | NHSA |
| 海南林恒制药股份有限公司 | 国药准字H20243520 | 40mg | Category B (乙) | XM04AAF670A001010605792 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20213864 | 40mg | Category B (乙) | XM04AAF670A001010610323 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20213091 | 40mg | Category B (乙) | XM04AAF670A001010680537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001010683521 | NHSA |
| 广州汇元医药科技有限公司 | 国药准字H20253470 | 40mg | Category B (乙) | XM04AAF670A001010683670 | NHSA |
| 一力制药(罗定)有限公司 | 国药准字H20223640 | 40mg | Category B (乙) | XM04AAF670A001010700311 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20130058 | 40mg | Category B (乙) | XM04AAF670A001010701729 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256296 | 40mg | Category B (乙) | XM04AAF670A001010702439 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20243755 | 40mg | Category B (乙) | XM04AAF670A001010702833 | NHSA |
| 山东力诺制药有限公司 | 国药准字H20233437 | 40mg | Category B (乙) | XM04AAF670A001010704023 | NHSA |
| 杭州朱养心药业有限公司 | 国药准字H20130009 | 40mg | Category B (乙) | XM04AAF670A001010704522 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20233472 | 40mg | Category B (乙) | XM04AAF670A001010704744 | NHSA |
| 海南林恒制药股份有限公司 | 国药准字H20243520 | 40mg | Category B (乙) | XM04AAF670A001010705792 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20213864 | 40mg | Category B (乙) | XM04AAF670A001010710323 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001010780537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001010783521 | NHSA |
| 一力制药(罗定)有限公司 | 国药准字H20223640 | 40mg | Category B (乙) | XM04AAF670A001010800311 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256296 | 40mg | Category B (乙) | XM04AAF670A001010802439 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20243755 | 40mg | Category B (乙) | XM04AAF670A001010802833 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20233472 | 40mg | Category B (乙) | XM04AAF670A001010804744 | NHSA |
| 海南林恒制药股份有限公司 | 国药准字H20243520 | 40mg | Category B (乙) | XM04AAF670A001010805792 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20213864 | 40mg | Category B (乙) | XM04AAF670A001010810323 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001010880537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001010883521 | NHSA |
| 一力制药(罗定)有限公司 | 国药准字H20223640 | 40mg | Category B (乙) | XM04AAF670A001010900311 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20243755 | 40mg | Category B (乙) | XM04AAF670A001010902833 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20233472 | 40mg | Category B (乙) | XM04AAF670A001010904744 | NHSA |
| 海南林恒制药股份有限公司 | 国药准字H20243520 | 40mg | Category B (乙) | XM04AAF670A001010905792 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20213864 | 40mg | Category B (乙) | XM04AAF670A001010910323 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001010980537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001010983521 | NHSA |
| 一力制药(罗定)有限公司 | 国药准字H20223640 | 40mg | Category B (乙) | XM04AAF670A001011000311 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20243755 | 40mg | Category B (乙) | XM04AAF670A001011002833 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20233472 | 40mg | Category B (乙) | XM04AAF670A001011004744 | NHSA |
| 海南林恒制药股份有限公司 | 国药准字H20243520 | 40mg | Category B (乙) | XM04AAF670A001011005792 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20213864 | 40mg | Category B (乙) | XM04AAF670A001011010323 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001011080537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001011083521 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20243755 | 40mg | Category B (乙) | XM04AAF670A001011102833 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20233472 | 40mg | Category B (乙) | XM04AAF670A001011104744 | NHSA |
| 海南林恒制药股份有限公司 | 国药准字H20243520 | 40mg | Category B (乙) | XM04AAF670A001011105792 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20213864 | 40mg | Category B (乙) | XM04AAF670A001011110323 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001011180537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001011183521 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20243755 | 40mg | Category B (乙) | XM04AAF670A001011202833 | NHSA |
| 海南林恒制药股份有限公司 | 国药准字H20243520 | 40mg | Category B (乙) | XM04AAF670A001011205792 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001011280537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001011283521 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20243755 | 40mg | Category B (乙) | XM04AAF670A001011302833 | NHSA |
| 海南林恒制药股份有限公司 | 国药准字H20243520 | 40mg | Category B (乙) | XM04AAF670A001011305792 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001011380537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001011383521 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20243755 | 40mg | Category B (乙) | XM04AAF670A001011402833 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001011480537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001011483521 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001011580537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001011583521 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001011680537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001011683521 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001011780537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001011783521 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001011880537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001011883521 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001011980537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001011983521 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001012080537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001012083521 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001012180537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001012183521 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001012280537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001012283521 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001012380537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001012383521 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001012480537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001012483521 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001012580537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001012583521 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20213091 | 40mg | Category B (乙) | XM04AAF670A001012680537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001012683521 | NHSA |
| 天方药业有限公司 | 国药准字H20213719 | 40mg | Category B (乙) | XM04AAF670A001012780537 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001012783521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001012883521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001012983521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001013083521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001013183521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001013283521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001013383521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233825 | 40mg | Category B (乙) | XM04AAF670A001013483521 | NHSA |
| 广东恒健制药有限公司 | 国药准字H20254760 | 40mg | Category B (乙) | XM04AAF670A001020100443 | NHSA |
| TEIJIN PHARMA LIMITED | 国药准字HJ20180050 | 40mg | Category B (乙) | XM04AAF670A001020101076 | NHSA |
| 江苏恒瑞医药股份有限公司 | 国药准字H20130082 | 80mg | Category B (乙) | XM04AAF670A001020101445 | NHSA |
| 南京海辰药业股份有限公司 | 国药准字H20243013 | 40mg | Category B (乙) | XM04AAF670A001020101563 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20130059 | 80mg | Category B (乙) | XM04AAF670A001020101729 | NHSA |
| 湖北广济药业股份有限公司 | 国药准字H20249848 | 20mg | Category B (乙) | XM04AAF670A001020101803 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20213926 | 40mg | Category B (乙) | XM04AAF670A001020102013 | NHSA |
| 四川依科制药有限公司 | 国药准字H20255107 | 20mg | Category B (乙) | XM04AAF670A001020102251 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256297 | 20mg | Category B (乙) | XM04AAF670A001020102439 | NHSA |
| 河北爱普制药有限公司 | 国药准字H20249299 | 20mg | Category B (乙) | XM04AAF670A001020102756 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20249288 | 20mg | Category B (乙) | XM04AAF670A001020102833 | NHSA |
| 吉林省辉南长龙生化药业股份有限公司 | 国药准字H20258145 | 20mg | Category B (乙) | XM04AAF670A001020103421 | NHSA |
| 山东力诺制药有限公司 | 国药准字H20233438 | 80mg | Category B (乙) | XM04AAF670A001020104023 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20233302 | 20mg | Category B (乙) | XM04AAF670A001020104043 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233189 | 20mg | Category B (乙) | XM04AAF670A001020104251 | NHSA |
| 杭州朱养心药业有限公司 | 国药准字H20130010 | 80mg | Category B (乙) | XM04AAF670A001020104522 | NHSA |
| 宁波美诺华天康药业有限公司 | 国药准字H20256169 | 20mg | Category B (乙) | XM04AAF670A001020104565 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20243042 | 80mg | Category B (乙) | XM04AAF670A001020104647 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20223766 | 40mg | Category B (乙) | XM04AAF670A001020104650 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20233473 | 20mg | Category B (乙) | XM04AAF670A001020104744 | NHSA |
| 江西施美药业股份有限公司 | 国药准字H20233131 | 20mg | Category B (乙) | XM04AAF670A001020105356 | NHSA |
| 重庆圣华曦药业股份有限公司 | 国药准字H20213860 | 40mg | Category B (乙) | XM04AAF670A001020109568 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20213864 | 40mg | Category B (乙) | XM04AAF670A001020110323 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20213092 | 80mg | Category B (乙) | XM04AAF670A001020180537 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213172 | 40mg | Category B (乙) | XM04AAF670A001020181457 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20249008 | 40mg | Category B (乙) | XM04AAF670A001020183198 | NHSA |
| 湖北亨迪药业股份有限公司 | 国药准字H20255686 | 20mg | Category B (乙) | XM04AAF670A001020183405 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233826 | 80mg | Category B (乙) | XM04AAF670A001020183521 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20233319 | 40mg | Category B (乙) | XM04AAF670A001020184209 | NHSA |
| 浙江赛默制药有限公司 | 国药准字H20263337 | 20mg | Category B (乙) | XM04AAF670A001020184214 | NHSA |
| 昆明龙津药业股份有限公司 | 国药准字H20233932 | 40mg | Category B (乙) | XM04AAF670A001020184519 | NHSA |
| 湖南状元制药有限公司 | 国药准字H20264930 | 40mg | Category B (乙) | XM04AAF670A001020184775 | NHSA |
| 南京海辰药业股份有限公司 | 国药准字H20243013 | 40mg | Category B (乙) | XM04AAF670A001020201563 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20130059 | 80mg | Category B (乙) | XM04AAF670A001020201729 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20213926 | 40mg | Category B (乙) | XM04AAF670A001020202013 | NHSA |
| 四川依科制药有限公司 | 国药准字H20255107 | 20mg | Category B (乙) | XM04AAF670A001020202251 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256297 | 20mg | Category B (乙) | XM04AAF670A001020202439 | NHSA |
| 河北爱普制药有限公司 | 国药准字H20249299 | 20mg | Category B (乙) | XM04AAF670A001020202756 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20249288 | 20mg | Category B (乙) | XM04AAF670A001020202833 | NHSA |
| 山东力诺制药有限公司 | 国药准字H20233438 | 80mg | Category B (乙) | XM04AAF670A001020204023 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233189 | 20mg | Category B (乙) | XM04AAF670A001020204251 | NHSA |
| 宁波美诺华天康药业有限公司 | 国药准字H20256169 | 20mg | Category B (乙) | XM04AAF670A001020204565 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20223766 | 40mg | Category B (乙) | XM04AAF670A001020204650 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20233473 | 20mg | Category B (乙) | XM04AAF670A001020204744 | NHSA |
| 江西施美药业股份有限公司 | 国药准字H20233131 | 20mg | Category B (乙) | XM04AAF670A001020205356 | NHSA |
| 重庆圣华曦药业股份有限公司 | 国药准字H20213860 | 40mg | Category B (乙) | XM04AAF670A001020209568 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20213864 | 40mg | Category B (乙) | XM04AAF670A001020210323 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20213092 | 80mg | Category B (乙) | XM04AAF670A001020280537 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213172 | 40mg | Category B (乙) | XM04AAF670A001020281457 | NHSA |
| 湖北亨迪药业股份有限公司 | 国药准字H20255686 | 20mg | Category B (乙) | XM04AAF670A001020283405 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233826 | 80mg | Category B (乙) | XM04AAF670A001020283521 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20233319 | 40mg | Category B (乙) | XM04AAF670A001020284209 | NHSA |
| 昆明龙津药业股份有限公司 | 国药准字H20233932 | 40mg | Category B (乙) | XM04AAF670A001020284519 | NHSA |
| 南京海辰药业股份有限公司 | 国药准字H20243013 | 40mg | Category B (乙) | XM04AAF670A001020301563 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20213926 | 40mg | Category B (乙) | XM04AAF670A001020302013 | NHSA |
| 四川依科制药有限公司 | 国药准字H20255107 | 20mg | Category B (乙) | XM04AAF670A001020302251 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256297 | 20mg | Category B (乙) | XM04AAF670A001020302439 | NHSA |
| 河北爱普制药有限公司 | 国药准字H20249299 | 20mg | Category B (乙) | XM04AAF670A001020302756 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20249288 | 20mg | Category B (乙) | XM04AAF670A001020302833 | NHSA |
| 山东力诺制药有限公司 | 国药准字H20233438 | 80mg | Category B (乙) | XM04AAF670A001020304023 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233189 | 20mg | Category B (乙) | XM04AAF670A001020304251 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20223766 | 40mg | Category B (乙) | XM04AAF670A001020304650 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20233473 | 20mg | Category B (乙) | XM04AAF670A001020304744 | NHSA |
| 重庆圣华曦药业股份有限公司 | 国药准字H20213860 | 40mg | Category B (乙) | XM04AAF670A001020309568 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20213864 | 40mg | Category B (乙) | XM04AAF670A001020310323 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20213092 | 80mg | Category B (乙) | XM04AAF670A001020380537 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213172 | 40mg | Category B (乙) | XM04AAF670A001020381457 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233826 | 80mg | Category B (乙) | XM04AAF670A001020383521 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20233319 | 40mg | Category B (乙) | XM04AAF670A001020384209 | NHSA |
| 南京海辰药业股份有限公司 | 国药准字H20243013 | 40mg | Category B (乙) | XM04AAF670A001020401563 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20213926 | 40mg | Category B (乙) | XM04AAF670A001020402013 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256297 | 20mg | Category B (乙) | XM04AAF670A001020402439 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20249288 | 20mg | Category B (乙) | XM04AAF670A001020402833 | NHSA |
| 山东力诺制药有限公司 | 国药准字H20233438 | 80mg | Category B (乙) | XM04AAF670A001020404023 | NHSA |
| 浙江华义制药有限公司 | 国药准字H20223766 | 40mg | Category B (乙) | XM04AAF670A001020404650 | NHSA |
| 重庆圣华曦药业股份有限公司 | 国药准字H20213860 | 40mg | Category B (乙) | XM04AAF670A001020409568 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20213864 | 40mg | Category B (乙) | XM04AAF670A001020410323 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20213092 | 80mg | Category B (乙) | XM04AAF670A001020480537 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213172 | 40mg | Category B (乙) | XM04AAF670A001020481457 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233826 | 80mg | Category B (乙) | XM04AAF670A001020483521 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20233319 | 40mg | Category B (乙) | XM04AAF670A001020484209 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20213926 | 40mg | Category B (乙) | XM04AAF670A001020502013 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256297 | 20mg | Category B (乙) | XM04AAF670A001020502439 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20249288 | 20mg | Category B (乙) | XM04AAF670A001020502833 | NHSA |
| 山东力诺制药有限公司 | 国药准字H20233438 | 80mg | Category B (乙) | XM04AAF670A001020504023 | NHSA |
| 重庆圣华曦药业股份有限公司 | 国药准字H20213860 | 40mg | Category B (乙) | XM04AAF670A001020509568 | NHSA |
| 珠海和凡医药股份有限公司 | 国药准字H20213864 | 40mg | Category B (乙) | XM04AAF670A001020510323 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20213092 | 80mg | Category B (乙) | XM04AAF670A001020580537 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213172 | 40mg | Category B (乙) | XM04AAF670A001020581457 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20233826 | 80mg | Category B (乙) | XM04AAF670A001020583521 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20213926 | 40mg | Category B (乙) | XM04AAF670A001020602013 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256297 | 20mg | Category B (乙) | XM04AAF670A001020602439 | NHSA |
| 涿州东乐制药有限公司 | 国药准字H20249288 | 20mg | Category B (乙) | XM04AAF670A001020602833 | NHSA |
| 山东力诺制药有限公司 | 国药准字H20233438 | 80mg | Category B (乙) | XM04AAF670A001020604023 | NHSA |
| 重庆圣华曦药业股份有限公司 | 国药准字H20213860 | 40mg | Category B (乙) | XM04AAF670A001020609568 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20213092 | 80mg | Category B (乙) | XM04AAF670A001020680537 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213172 | 40mg | Category B (乙) | XM04AAF670A001020681457 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20233319 | 40mg | Category B (乙) | XM04AAF670A001020684209 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20213926 | 40mg | Category B (乙) | XM04AAF670A001020702013 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256297 | 20mg | Category B (乙) | XM04AAF670A001020702439 | NHSA |
| 重庆圣华曦药业股份有限公司 | 国药准字H20213860 | 40mg | Category B (乙) | XM04AAF670A001020709568 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213172 | 40mg | Category B (乙) | XM04AAF670A001020781457 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20233319 | 40mg | Category B (乙) | XM04AAF670A001020784209 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256297 | 20mg | Category B (乙) | XM04AAF670A001020802439 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213172 | 40mg | Category B (乙) | XM04AAF670A001020881457 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20233319 | 40mg | Category B (乙) | XM04AAF670A001020884209 | NHSA |
| 陕西西岳制药有限公司 | 国药准字H20256297 | 20mg | Category B (乙) | XM04AAF670A001020902439 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213172 | 40mg | Category B (乙) | XM04AAF670A001020981457 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20233319 | 40mg | Category B (乙) | XM04AAF670A001020984209 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213172 | 40mg | Category B (乙) | XM04AAF670A001021081457 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20233319 | 40mg | Category B (乙) | XM04AAF670A001021084209 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213172 | 40mg | Category B (乙) | XM04AAF670A001021181457 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20233319 | 40mg | Category B (乙) | XM04AAF670A001021184209 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213172 | 40mg | Category B (乙) | XM04AAF670A001021281457 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213172 | 40mg | Category B (乙) | XM04AAF670A001021381457 | NHSA |
| 中美华世通生物医药科技(武汉)股份有限公司 | 国药准字H20213172 | 40mg | Category B (乙) | XM04AAF670A001021481457 | NHSA |
| 江苏恒瑞医药股份有限公司 | 国药准字H20213689 | 20mg | Category B (乙) | XM04AAF670A001030101445 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233188 | 40mg | Category B (乙) | XM04AAF670A001030104251 | NHSA |
| 杭州朱养心药业有限公司 | 国药准字H20205030 | 20mg | Category B (乙) | XM04AAF670A001030104522 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001030180537 | NHSA |
| 江苏恒瑞医药股份有限公司 | 国药准字H20213689 | 20mg | Category B (乙) | XM04AAF670A001030201445 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20205023 | 20mg | Category B (乙) | XM04AAF670A001030201729 | NHSA |
| 杭州朱养心药业有限公司 | 国药准字H20205030 | 20mg | Category B (乙) | XM04AAF670A001030204522 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001030280537 | NHSA |
| 江苏恒瑞医药股份有限公司 | 国药准字H20213689 | 20mg | Category B (乙) | XM04AAF670A001030301445 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20205023 | 20mg | Category B (乙) | XM04AAF670A001030301729 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001030380537 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20205023 | 20mg | Category B (乙) | XM04AAF670A001030401729 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001030480537 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20205023 | 20mg | Category B (乙) | XM04AAF670A001030501729 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001030580537 | NHSA |
| 复星万邦(江苏)医药集团有限公司 | 国药准字H20205023 | 20mg | Category B (乙) | XM04AAF670A001030601729 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001030680537 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001030780537 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001030880537 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001030980537 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001031080537 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001031180537 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001031280537 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001031380537 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001031480537 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001031580537 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001031680537 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001031780537 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001031880537 | NHSA |
| 天方药业有限公司 | 国药准字H20213720 | 20mg | Category B (乙) | XM04AAF670A001031980537 | NHSA |
| 江苏恒瑞医药股份有限公司 | 国药准字H20130081 | 40mg | Category B (乙) | XM04AAF670A001040101445 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233188 | 40mg | Category B (乙) | XM04AAF670A001040104251 | NHSA |
| 杭州朱养心药业有限公司 | 国药准字H20205030 | 20mg | Category B (乙) | XM04AAF670A001040104522 | NHSA |
| 杭州朱养心药业有限公司 | 国药准字H20205030 | 20mg | Category B (乙) | XM04AAF670A001040304522 | NHSA |
| 杭州朱养心药业有限公司 | 国药准字H20205030 | 20mg | Category B (乙) | XM04AAF670A001040404522 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233188 | 40mg | Category B (乙) | XM04AAF670A001050104251 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233188 | 40mg | Category B (乙) | XM04AAF670A001060104251 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233188 | 40mg | Category B (乙) | XM04AAF670A001070104251 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233188 | 40mg | Category B (乙) | XM04AAF670A001080104251 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233188 | 40mg | Category B (乙) | XM04AAF670A001090104251 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233188 | 40mg | Category B (乙) | XM04AAF670A001100104251 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233188 | 40mg | Category B (乙) | XM04AAF670A001110104251 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233188 | 40mg | Category B (乙) | XM04AAF670A001120104251 | NHSA |
| 福安药业集团烟台只楚药业有限公司 | 国药准字H20233188 | 40mg | Category B (乙) | XM04AAF670A001130104251 | NHSA |
| 广州汇元医药科技有限公司 | 国药准字H20253470 | 40mg | Category B (乙) | XM04AAF670A001010783670 | NHSA |
| 广州汇元医药科技有限公司 | 国药准字H20253470 | 40mg | Category B (乙) | XM04AAF670A001010883670 | NHSA |
| 广州汇元医药科技有限公司 | 国药准字H20253470 | 40mg | Category B (乙) | XM04AAF670A001010983670 | NHSA |
| 广州汇元医药科技有限公司 | 国药准字H20253470 | 40mg | Category B (乙) | XM04AAF670A001011083670 | NHSA |
| 广州汇元医药科技有限公司 | 国药准字H20253470 | 40mg | Category B (乙) | XM04AAF670A001011183670 | NHSA |
| 广州汇元医药科技有限公司 | 国药准字H20253470 | 40mg | Category B (乙) | XM04AAF670A001011283670 | NHSA |
| 广州汇元医药科技有限公司 | 国药准字H20253470 | 40mg | Category B (乙) | XM04AAF670A001011383670 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20233319 | 40mg | Category B (乙) | XM04AAF670A001021284209 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 14 filings and 9 distinct first applicants.
Generic 13 · Supplement 1
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 迪沙药业集团有限公司 | CYHS2502268 | Generic | 2025/06/24 | Not stated by source | CDE |
| 山东淄博新达制药有限公司 | CYHB2601655 | Supplement | 2026/08/28 | Not stated by source | CDE |
| 山西同达药业有限公司 | CYHS2602060 | Generic | 2026/08/20 | Not stated by source | CDE |
| 山西同达药业有限公司 | CYHS2602059 | Generic | 2026/08/20 | Not stated by source | CDE |
| 广东彼迪药业有限公司 | CYHS2602044 | Generic | 2026/08/18 | Not stated by source | CDE |
| 广东彼迪药业有限公司 | CYHS2602043 | Generic | 2026/08/18 | Not stated by source | CDE |
| 广州市联瑞制药有限公司 | CYHS2600828 | Generic | 2026/04/10 | Not stated by source | CDE |
| 哈尔滨中泰医药有限公司;哈尔滨三三药业有限公司 | CYHS2600676 | Generic | 2026/03/19 | Not stated by source | CDE |
| 山西汾河制药有限公司 | CYHS2600372 | Generic | 2026/02/05 | Not stated by source | CDE |
| 山西汾河制药有限公司 | CYHS2600371 | Generic | 2026/02/05 | Not stated by source | CDE |
| 陕西天宇制药有限公司;四川昇锐制药有限公司 | CYHS2504289 | Generic | 2025/12/16 | Not stated by source | CDE |
| 陕西天宇制药有限公司;四川昇锐制药有限公司 | CYHS2504288 | Generic | 2025/12/16 | Not stated by source | CDE |
| 天津力生制药股份有限公司 | CYHS2502261 | Generic | 2025/06/24 | Not stated by source | CDE |
| 天津力生制药股份有限公司 | CYHS2502260 | Generic | 2025/06/24 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 8 filings and 5 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 山西同达药业有限公司 | CYHS2602060 | Generic | 2026/08/20 | Not stated by source | CDE |
| 山西同达药业有限公司 | CYHS2602059 | Generic | 2026/08/20 | Not stated by source | CDE |
| 广东彼迪药业有限公司 | CYHS2602044 | Generic | 2026/08/18 | Not stated by source | CDE |
| 广东彼迪药业有限公司 | CYHS2602043 | Generic | 2026/08/18 | Not stated by source | CDE |
| 广州市联瑞制药有限公司 | CYHS2600828 | Generic | 2026/04/10 | Not stated by source | CDE |
| 哈尔滨中泰医药有限公司;哈尔滨三三药业有限公司 | CYHS2600676 | Generic | 2026/03/19 | Not stated by source | CDE |
| 山西汾河制药有限公司 | CYHS2600372 | Generic | 2026/02/05 | Not stated by source | CDE |
| 山西汾河制药有限公司 | CYHS2600371 | Generic | 2026/02/05 | Not stated by source | CDE |
API registrations
Non-component matches: 34 companies with A status and 7 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 非布司他 | 陕西西岳制药（扶风）有限公司 | Y20250000451 | A | Exact ingredient | 2026/10/29 | CDE |
| 非布司他 | 上海锦帝九州药业（安阳）有限公司 | Y20240001487 | A | Exact ingredient | 2026/07/23 | CDE |
| 非布司他 | 江苏德源药业股份有限公司 | Y20240001384 | A | Exact ingredient | 2026/03/20 | CDE |
| 非布司他 | 峨眉山鸿森生物医药股份有限公司 | Y20240000935 | A | Exact ingredient | 2026/07/15 | CDE |
| 非布司他 | Metrochem API Private Limited | Y20240001001 | A | Exact ingredient | 2026/08/14 | CDE |
| 非布司他 | 天方药业有限公司 | Y20230001027 | A | Exact ingredient | 2025/03/21 | CDE |
| 非布司他 | MSN Organics Private Limited. | Y20230000399 | I | Exact ingredient | 2025/09/22 | CDE |
| 非布司他 | 白云山东泰商丘药业有限公司 | Y20230000646 | A | Exact ingredient | 2025/11/18 | CDE |
| 非布司他 | 峨眉山宏昇药业股份有限公司 | Y20220001326 | I | Exact ingredient | 2023/06/14 | CDE |
| 非布司他 | 沧州维智达美制药有限公司 | Y20220000850 | A | Exact ingredient | 2025/03/24 | CDE |
| 非布司他 | 南京海辰药业股份有限公司 | Y20210000817 | A | Exact ingredient | 2025/03/19 | CDE |
| 非布司他 | 山东新华制药股份有限公司 | Y20210001232 | A | Exact ingredient | 2023/10/09 | CDE |
| 非布司他 | 山东鲁抗医药股份有限公司 | Y20210001139 | A | Exact ingredient | 2025/07/21 | CDE |
| 非布司他 | 福建金山准点制药有限公司 | Y20210001038 | A | Exact ingredient | 2024/02/28 | CDE |
| 非布司他 | 浙江华海药业股份有限公司 | Y20210001006 | A | Exact ingredient | 2025/05/31 | CDE |
| 非布司他 | 天津力生制药股份有限公司 | Y20210000954 | A | Exact ingredient | 2023/08/21 | CDE |
| 非布司他 | 福建金山准点制药有限公司 | Y20210000739 | I | Exact ingredient | 2021/09/22 | CDE |
| 非布司他 | 江西同和药业股份有限公司 | Y20200001229 | A | Exact ingredient | 2026/05/20 | CDE |
| 非布司他 | 福安药业集团重庆博圣制药有限公司 | Y20200001267 | A | Exact ingredient | 2026/10/26 | CDE |
| 非布司他 | 湖南方盛制药股份有限公司 | Y20200001076 | A | Exact ingredient | 2023/03/16 | CDE |
| 非布司他 | 江苏九阳生物制药有限公司 | Y20200000951 | I | Exact ingredient | 2020/09/25 | CDE |
| 非布司他 | 迪嘉药业集团股份有限公司 | Y20200000997 | A | Exact ingredient | 2026/09/30 | CDE |
| 非布司他 | 浙江天宇药业股份有限公司 | Y20200000913 | A | Exact ingredient | 2026/08/13 | CDE |
| 非布司他 | 浙江东亚药业股份有限公司 | Y20200000264 | A | Exact ingredient | 2022/11/04 | CDE |
| 非布司他 | 山东朗诺制药有限公司 | Y20200000278 | A | Exact ingredient | 2026/07/24 | CDE |
| 非布司他 | 苏州弘森药业股份有限公司 | Y20200000273 | A | Exact ingredient | 2026/07/17 | CDE |
| 非布司他 | 山东铂源药业股份有限公司 | Y20190021233 | A | Exact ingredient | 2026/03/14 | CDE |
| 非布司他 | 重庆圣华曦药业股份有限公司 | Y20190021276 | A | Exact ingredient | 2026/07/09 | CDE |
| 非布司他 | 浙江奥翔药业股份有限公司 | Y20190000927 | A | Exact ingredient | 2026/08/15 | CDE |
| 非布司他 | 天津泰普制药有限公司 | Y20190021284 | A | Exact ingredient | 2026/04/23 | CDE |
| 非布司他 | 江苏恒瑞医药股份有限公司 | Y20190009853 | A | Exact ingredient | — | CDE |
| 非布司他 | 徐州万邦金桥制药有限公司 | Y20190009847 | A | Exact ingredient | — | CDE |
| 非布司他 | 杭州中美华东制药有限公司 | Y20190008902 | A | Exact ingredient | 2023/03/24 | CDE |
| 非布司他 | 徐州万邦金桥制药有限公司 | Y20190000464 | A | Exact ingredient | 2025/03/23 | CDE |
| 非布司他 | 宜昌东阳光长江药业股份有限公司 | Y20190000112 | A | Exact ingredient | 2026/01/29 | CDE |
| 非布司他 | 江苏恒瑞医药股份有限公司 | Y20180001327 | A | Exact ingredient | 2025/03/19 | CDE |
| 非布司他 | 扬子江药业集团江苏海慈生物药业有限公司 | Y20180001161 | I | Exact ingredient | 2018/09/14 | CDE |
| 非布司他 | 湖北华世通生物医药科技有限公司 | Y20180001003 | A | Exact ingredient | 2026/01/29 | CDE |
| 非布司他 | 浙江华海药业股份有限公司 | Y20180000878 | I | Exact ingredient | — | CDE |
| 非布司他 | 浙江华义制药有限公司 | Y20170001633 | A | Exact ingredient | 2026/02/10 | CDE |
| 非布司他 | 康普药业股份有限公司 | Y20170001410 | A | Exact ingredient | 2023/05/16 | CDE |
| 非布司他 | Alembic Pharmaceuticals Ltd. | Y20170000776 | A | Exact ingredient | 2022/10/21 | CDE |
| 非布司他 | 珠海联邦制药股份有限公司 | Y20170000495 | I | Exact ingredient | — | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/11/04No longer listed under review
MSN Laboratories Private limited;Luoxin Pharmaceutical（Shanghai）Co. Ltd.
JYHS2101022
Fact date: 2026/11/04 · Site observation date: 2026/11/04
Accepted: 2021/06/29
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/11/03No longer listed under review
MSN Laboratories Private limited;Luoxin Pharmaceutical（Shanghai）Co. Ltd.
JYHS2101021
Fact date: 2026/11/03 · Site observation date: 2026/11/03
Accepted: 2021/06/29
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/08/28Accepted
-
2026/08/20Accepted
-
2026/08/20Accepted
-
2026/08/18Accepted
-
2026/08/18Accepted
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Febuxostat Tablets
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy